These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27351590)

  • 1. Liganded Vitamin D Receptor Through Its Interacting Repressor Inhibits the Expression of Type I Collagen α1.
    Wan LY; Zhang YQ; Li JM; Tang HQ; Chen MD; Ni YR; Huang H; Liu CB; Wu JF
    DNA Cell Biol; 2016 Sep; 35(9):498-505. PubMed ID: 27351590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter.
    Kim MS; Fujiki R; Murayama A; Kitagawa H; Yamaoka K; Yamamoto Y; Mihara M; Takeyama K; Kato S
    Mol Endocrinol; 2007 Feb; 21(2):334-42. PubMed ID: 17095575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.
    Murayama A; Kim MS; Yanagisawa J; Takeyama K; Kato S
    EMBO J; 2004 Apr; 23(7):1598-608. PubMed ID: 15934135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
    Prüfer K; Barsony J
    Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.
    Meyer MB; Goetsch PD; Pike JW
    Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action.
    Lundqvist J; Wikvall K; Norlin M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1553-9. PubMed ID: 22561756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of structure and function of DNA-binding domain in vitamin D receptor.
    Wan LY; Zhang YQ; Chen MD; Liu CB; Wu JF
    Molecules; 2015 Jul; 20(7):12389-99. PubMed ID: 26198224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
    Jiménez-Lara AM; Aranda A
    Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol potentiates vitamin D and nuclear receptor signaling.
    Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
    J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
    Barletta F; Freedman LP; Christakos S
    Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.